Tropatepine

DB13252

small molecule experimental

Deskripsi

Tropatepine has been used in France for its antiparkinsons activities A175024.

Struktur Molekul 2D

Berat 333.49
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

552 Data
Aclidinium The risk or severity of adverse effects can be increased when Tropatepine is combined with Aclidinium.
Mianserin Mianserin may increase the anticholinergic activities of Tropatepine.
Mirabegron The risk or severity of urinary retention can be increased when Tropatepine is combined with Mirabegron.
Potassium chloride The risk or severity of gastrointestinal ulceration can be increased when Tropatepine is combined with Potassium chloride.
Pramlintide The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Tropatepine.
Secretin porcine The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Tropatepine.
Tiotropium The risk or severity of adverse effects can be increased when Tropatepine is combined with Tiotropium.
Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Tropatepine is combined with Topiramate.
Umeclidinium The risk or severity of adverse effects can be increased when Tropatepine is combined with Umeclidinium.
Methylphenidate The risk or severity of adverse effects can be increased when Methylphenidate is combined with Tropatepine.
Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Tropatepine.
Metoclopramide The therapeutic efficacy of Tropatepine can be decreased when used in combination with Metoclopramide.
Glycopyrronium The risk or severity of adverse effects can be increased when Tropatepine is combined with Glycopyrronium.
Botulinum toxin type A The risk or severity of adverse effects can be increased when Tropatepine is combined with Botulinum toxin type A.
Glucagon Tropatepine may increase the gastrointestinal motility reducing activities of Glucagon.
Sulpiride Tropatepine may increase the anticholinergic activities of Sulpiride.
Botulinum toxin type B The risk or severity of adverse effects can be increased when Tropatepine is combined with Botulinum toxin type B.
Eluxadoline The risk or severity of constipation can be increased when Tropatepine is combined with Eluxadoline.
Ramosetron The risk or severity of constipation can be increased when Tropatepine is combined with Ramosetron.
Naltrexone The risk or severity of adverse effects can be increased when Tropatepine is combined with Naltrexone.
Bezitramide The risk or severity of adverse effects can be increased when Tropatepine is combined with Bezitramide.
Tramadol The risk or severity of adverse effects can be increased when Tropatepine is combined with Tramadol.
Morphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Morphine.
Codeine The risk or severity of adverse effects can be increased when Tropatepine is combined with Codeine.
Hydromorphone The risk or severity of adverse effects can be increased when Tropatepine is combined with Hydromorphone.
Methadone The risk or severity of adverse effects can be increased when Tropatepine is combined with Methadone.
Meperidine The risk or severity of adverse effects can be increased when Tropatepine is combined with Meperidine.
Oxycodone The risk or severity of adverse effects can be increased when Tropatepine is combined with Oxycodone.
Butorphanol The risk or severity of adverse effects can be increased when Tropatepine is combined with Butorphanol.
Dextropropoxyphene The risk or severity of adverse effects can be increased when Tropatepine is combined with Dextropropoxyphene.
Pentazocine The risk or severity of adverse effects can be increased when Tropatepine is combined with Pentazocine.
Sufentanil The risk or severity of adverse effects can be increased when Tropatepine is combined with Sufentanil.
Alfentanil The risk or severity of adverse effects can be increased when Tropatepine is combined with Alfentanil.
Fentanyl The risk or severity of adverse effects can be increased when Tropatepine is combined with Fentanyl.
Nalbuphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Nalbuphine.
Levorphanol The risk or severity of adverse effects can be increased when Tropatepine is combined with Levorphanol.
Remifentanil The risk or severity of adverse effects can be increased when Tropatepine is combined with Remifentanil.
Buprenorphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Buprenorphine.
Hydrocodone The risk or severity of adverse effects can be increased when Tropatepine is combined with Hydrocodone.
Diphenoxylate The risk or severity of adverse effects can be increased when Tropatepine is combined with Diphenoxylate.
Oxymorphone The risk or severity of adverse effects can be increased when Tropatepine is combined with Oxymorphone.
Dezocine The risk or severity of adverse effects can be increased when Tropatepine is combined with Dezocine.
Levacetylmethadol The risk or severity of adverse effects can be increased when Tropatepine is combined with Levacetylmethadol.
Methadyl acetate The risk or severity of adverse effects can be increased when Tropatepine is combined with Methadyl acetate.
Dihydroetorphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Dihydroetorphine.
Diamorphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Diamorphine.
Ethylmorphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Ethylmorphine.
Etorphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Etorphine.
Dextromoramide The risk or severity of adverse effects can be increased when Tropatepine is combined with Dextromoramide.
Desomorphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Desomorphine.
Carfentanil The risk or severity of adverse effects can be increased when Tropatepine is combined with Carfentanil.
Dihydrocodeine The risk or severity of adverse effects can be increased when Tropatepine is combined with Dihydrocodeine.
Alphacetylmethadol The risk or severity of adverse effects can be increased when Tropatepine is combined with Alphacetylmethadol.
Dihydromorphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Dihydromorphine.
Tapentadol The risk or severity of urinary retention and constipation can be increased when Tropatepine is combined with Tapentadol.
Ketobemidone The risk or severity of adverse effects can be increased when Tropatepine is combined with Ketobemidone.
DPDPE The risk or severity of adverse effects can be increased when Tropatepine is combined with DPDPE.
Lofentanil The risk or severity of adverse effects can be increased when Tropatepine is combined with Lofentanil.
Opium The risk or severity of adverse effects can be increased when Tropatepine is combined with Opium.
Normethadone The risk or severity of adverse effects can be increased when Tropatepine is combined with Normethadone.
Piritramide The risk or severity of adverse effects can be increased when Tropatepine is combined with Piritramide.
Alphaprodine The risk or severity of adverse effects can be increased when Tropatepine is combined with Alphaprodine.
Nicomorphine The risk or severity of adverse effects can be increased when Tropatepine is combined with Nicomorphine.
Meptazinol The risk or severity of adverse effects can be increased when Tropatepine is combined with Meptazinol.
Phenoperidine The risk or severity of adverse effects can be increased when Tropatepine is combined with Phenoperidine.
Phenazocine The risk or severity of adverse effects can be increased when Tropatepine is combined with Phenazocine.
Tilidine The risk or severity of adverse effects can be increased when Tropatepine is combined with Tilidine.
Carfentanil, C-11 The risk or severity of adverse effects can be increased when Tropatepine is combined with Carfentanil, C-11.
Benzhydrocodone The risk or severity of adverse effects can be increased when Tropatepine is combined with Benzhydrocodone.
Naloxegol The risk or severity of adverse effects can be increased when Tropatepine is combined with Naloxegol.
Trospium The risk or severity of adverse effects can be increased when Trospium is combined with Tropatepine.
Oxyphenonium The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tropatepine.
Benzatropine The risk or severity of adverse effects can be increased when Benzatropine is combined with Tropatepine.
Disopyramide The risk or severity of adverse effects can be increased when Disopyramide is combined with Tropatepine.
Metixene The risk or severity of adverse effects can be increased when Metixene is combined with Tropatepine.
Terfenadine The risk or severity of adverse effects can be increased when Terfenadine is combined with Tropatepine.
Buclizine The risk or severity of adverse effects can be increased when Buclizine is combined with Tropatepine.
Trihexyphenidyl The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Tropatepine.
Oxyphencyclimine The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Tropatepine.
Procyclidine The risk or severity of adverse effects can be increased when Procyclidine is combined with Tropatepine.
Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Tropatepine.
Methscopolamine bromide The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Tropatepine.
Darifenacin The risk or severity of adverse effects can be increased when Darifenacin is combined with Tropatepine.
Tridihexethyl The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Tropatepine.
Anisotropine methylbromide The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Tropatepine.
Atropine The risk or severity of adverse effects can be increased when Atropine is combined with Tropatepine.
Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Tropatepine.
Mecamylamine The risk or severity of adverse effects can be increased when Mecamylamine is combined with Tropatepine.
Pirenzepine The risk or severity of adverse effects can be increased when Pirenzepine is combined with Tropatepine.
Homatropine methylbromide The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Tropatepine.
Benzquinamide The risk or severity of adverse effects can be increased when Benzquinamide is combined with Tropatepine.
Propantheline The risk or severity of adverse effects can be increased when Propantheline is combined with Tropatepine.
Dicyclomine The risk or severity of adverse effects can be increased when Dicyclomine is combined with Tropatepine.
Tropicamide The risk or severity of adverse effects can be increased when Tropicamide is combined with Tropatepine.
Cocaine The risk or severity of adverse effects can be increased when Cocaine is combined with Tropatepine.
Quinidine The risk or severity of adverse effects can be increased when Quinidine is combined with Tropatepine.
Amantadine The risk or severity of adverse effects can be increased when Amantadine is combined with Tropatepine.
Methantheline The risk or severity of adverse effects can be increased when Methantheline is combined with Tropatepine.
Cycrimine The risk or severity of adverse effects can be increased when Cycrimine is combined with Tropatepine.
Cyclopentolate The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Tropatepine.

Referensi & Sumber

Artikel (PubMed)

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul